Protein Assays Market to Grow with a CAGR of 6.40% through 2030

Rising Incidence of Chronic Diseases and Aging Population and Increasing R&D Investment in Drug Discovery and Development are expected to drive the Global Protein Assays Market growth in the forecast period, 2026-2030

According to TechSci Research report, “Protein Assays Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2030F”, the Global Protein Assays Market stood at USD 2.72 Billion in 2024 and is anticipated to grow with a CAGR of 6.40% in the forecast period.

The healthcare industry’s shift toward personalized and precision medicine is accelerating the adoption of protein assays as indispensable diagnostic tools. These assays provide critical insights into protein biomarkers associated with disease progression, therapeutic response, and patient segmentation, enabling targeted treatment strategies. In oncology and immunology, protein assays are increasingly embedded into companion diagnostic workflows to identify patients likely to respond to targeted therapies, thereby improving treatment outcomes and reimbursement strategies. Hospitals and academic centers are scaling investments in protein biomarker discovery and validation, particularly for chronic and orphan diseases. This drives recurring demand for high-sensitivity assay kits and platforms. The expansion of point-of-care diagnostics is creating a growing market for rapid, assay-based kits that enable protein biomarker detection at bedside or in decentralized lab settings.

The rapid expansion of biologics manufacturing including monoclonal antibodies, recombinant proteins, and cell therapies is significantly boosting the need for protein assays used in product quality control, batch testing, and regulatory compliance. Protein assays are integral in confirming product integrity, potency, and purity across manufacturing lots, a critical requirement for FDA/EMA approval. Leading biopharma companies are investing in protein quantification tools for upstream and downstream process optimization, aiming to improve product consistency and manufacturing yield. The ongoing use of assays in validated manufacturing environments creates long-term demand, as every production cycle requires stringent protein analysis, supporting a consumables-driven revenue model.

Technological innovation is transforming protein quantification, with the emergence of label-free detection, microfluidics, multiplexing, and ultra-sensitive dyes. These advancements are reducing turnaround times, enhancing reproducibility, and enabling the detection of low-abundance proteins. Pharma and biotech firms are adopting platforms that support hundreds of simultaneous assays, accelerating compound screening and protein interaction studies. Demand is rising for low-volume, high-sensitivity assays suited for rare samples or single-cell studies, especially in cancer immunotherapy and stem cell research. Multiplex assays that simultaneously detect multiple protein targets in a single run offer significant cost and time efficiencies, increasing adoption in both academic and commercial research settings.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Protein Assays Market”

The Global Protein Assays Market is segmented into type, product, technology, application, end user, regional distribution, and company.

Based on technology, the Colorimetric Protein Assays segment has emerged as the predominant market leader, Colorimetric assays, such as the Bradford, BCA, and Lowry methods, are widely preferred due to their straightforward protocols and minimal need for complex instrumentation. These assays rely on visible color change upon protein binding, making them highly accessible for routine lab workflows across academic, industrial, and clinical environments. Compatible with basic spectrophotometers or plate readers, making them suitable for both high-throughput and resource-limited settings. Enables quick protein quantification with relatively short incubation and readout times.

Colorimetric assays offer a low-cost solution for routine protein quantification. The reagents used are inexpensive, and the assay procedures can be scaled easily without significant investment in high-end detection systems. Especially in QC labs and CROs where cost per test is a key consideration. Attracts adoption in emerging markets and among smaller labs with limited budgets. Colorimetric protein assays are compatible with a wide range of biological sample matrices, including serum, plasma, cell lysates, and tissue homogenates. This broad compatibility increases their relevance across multiple applications from academic research to biopharma manufacturing. Modern colorimetric kits have been optimized to reduce interference from buffers, detergents, and reducing agents.

Based on its application, the Drug Discovery and Development segment has emerged as the predominant market leader, Protein assays are central to the early phases of drug discovery, where researchers must identify and validate disease-related proteins as drug targets. Accurate quantification and profiling of protein expression are critical to understanding biological pathways and determining therapeutic potential. Enables researchers to evaluate protein activity and expression levels across conditions. Assists in analyzing how a candidate drug interacts with its target protein and influences downstream signaling.

Throughout the preclinical and clinical trial phases, protein assays are indispensable in evaluating pharmacodynamics, biomarker levels, and toxicity profiles. They help ensure the safety, efficacy, and mechanism validation of new drug candidates. Supports the development of personalized treatment strategies and patient stratification. Facilitates precision in optimizing drug dosing by monitoring therapeutic protein levels. The rise of biologic drugs such as monoclonal antibodies, recombinant proteins, and enzyme therapies has significantly expanded the need for protein assays in drug formulation, stability testing, and quality assurance. As more biopharmaceuticals enter the pipeline, protein assay demand continues to grow. Assays are integrated into upstream and downstream processes to optimize yield and purity. Regulatory agencies (FDA, EMA, etc.) require extensive protein characterization for approval of biologics.

Based on region, The Asia Pacific region is positioned to be the fastest-growing market in the Global Protein Assays Market over the forecast period. This growth trajectory is driven by a combination of rising healthcare investments, expanding pharmaceutical and biotechnology sectors, increasing R&D activity, and favorable government initiatives supporting life sciences innovation.

Countries such as China, India, South Korea, and Singapore are witnessing rapid growth in biopharmaceutical production and biologics R&D. This surge in activity directly fuels demand for protein assays used in drug development, quality control, and manufacturing processes. China’s “Made in China 2025” and India’s “Make in India” initiatives are boosting domestic drug and biotech production capabilities. Multinational pharma companies are increasingly outsourcing clinical trials and biologics manufacturing to APAC due to cost advantages and skilled labor availability.

Governments across the region are heavily investing in academic and translational research infrastructure, driving the demand for protein analysis tools in both academic and commercial laboratories. National research agencies in countries like Japan, Australia, and China are funding large-scale proteomics and biomarker discovery programs. Public-private partnerships and incentives are promoting collaboration between academia and industry, expanding assay adoption. With a growing middle-class population and rising healthcare awareness, disease diagnosis and clinical testing are increasing rapidly. Protein assays are critical tools in this expansion particularly for identifying biomarkers for chronic conditions such as cancer, diabetes, and cardiovascular diseases. Urbanization and rising healthcare access in countries like Indonesia, Vietnam, and the Philippines are opening new markets for diagnostic testing. Rapid expansion of hospitals, diagnostic labs, and point-of-care facilities is boosting the use of protein-based diagnostics.

Major companies operating in Global Protein Assays Market are:

• Becton Dickinson and Co
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories Inc
• Merck KGaA
• Abcam PLC
• PerkinElmer Inc.
• QIAGEN NV
• Lonza Group AG
• Bio-Techne Corp
• Illumina Inc

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“The Global Protein Assays Market is on a steady growth trajectory, driven by the rising demand for precise protein quantification across pharmaceutical R&D, clinical diagnostics, and biologics manufacturing. As technological innovation accelerates and healthcare systems worldwide place greater emphasis on targeted therapies and biomarker-driven diagnostics, protein assays will remain a critical tool for scientific advancement and commercial success. Companies that focus on developing high-performance, cost-effective, and scalable assay solutions while also expanding their presence in high-growth regions such as Asia Pacific will be well-positioned to capitalize on emerging opportunities in this dynamic and evolving market landscape.,” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“Protein Assays Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Type (Dye Binding Assays, Test Strip-Based Assays, Copper-Ion-Based Assays, Others), By Product (Reagents, Kits, Instruments and Accessories), By Technology (Colorimetric Protein Assays, Fluorescence-Based Protein Assays, Absorbance-Based Protein Assays), By Application (Drug Discovery and Development, Disease Diagnosis, Others), By End User (Pharmaceutical and Biotechnology Companies, Clinical Laboratories, Hospitals, Academic Research Institutes, Others), By Region & Competition, 2020-2030F”, has evaluated the future growth potential of Global Protein Assays Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Protein Assays Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]